Literature DB >> 32557415

Recreational diving in persons with type 1 and type 2 diabetes: Advancing capabilities and recommendations.

Johan H Jendle1,2,3, Peter Adolfsson2,4,5, Neal W Pollock6,7.   

Abstract

Diving by persons with diabetes has long been conducted, with formal guidelines published in the early 1990s. Subsequent consensus guidelines produced following a 2005 workshop helped to advance the recognition of relevant issues and promote discussion. The guidelines were intended as an interim step in guidance, with the expectation that revisions should follow the gathering of additional data and experience. Recent and ongoing developments in pharmacology and technology can further aid in reducing the risk of hypoglycemia, a critical acute concern of diving with diabetes. Careful and periodic evaluation remains crucial to ensure that participation in diving activity is appropriate. Close self-monitoring, thoughtful adjustments of medications and meals, and careful review of the individual response to diving can assist in optimising control and ensuring safety. Open communication with diving partners, support personnel, and medical monitors is important to ensure that all are prepared to effectively assist in case of need. Ongoing vigilance, best practice, including graduated clearance for diving exposures and adverse event reporting, are all required to ensure the safety of diving with diabetes and to promote community understanding and acceptance. Copyright: This article is the copyright of the authors who grant Diving and Hyperbaric Medicine a non-exclusive licence to publish the article in electronic and other forms.

Entities:  

Keywords:  Diving safety; Endocrinology; Health; Medical conditions and problems; Medications; Risk management

Mesh:

Year:  2020        PMID: 32557415      PMCID: PMC7481121          DOI: 10.28920/dhm50.2.135-143

Source DB:  PubMed          Journal:  Diving Hyperb Med        ISSN: 1833-3516            Impact factor:   0.887


  34 in total

1.  Differential diagnostic problems of decompression sickness--examples from specialist physicians' practices in diving medicine.

Authors:  Nadan M Petri; Dejan Andrić
Journal:  Arch Med Res       Date:  2003 Jan-Feb       Impact factor: 2.235

2.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

Authors:  David M Nathan; Patricia A Cleary; Jye-Yu C Backlund; Saul M Genuth; John M Lachin; Trevor J Orchard; Philip Raskin; Bernard Zinman
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

3.  ISPAD Clinical Practice Consensus Guidelines 2018: Exercise in children and adolescents with diabetes.

Authors:  Peter Adolfsson; Michael C Riddell; Craig E Taplin; Elizabeth A Davis; Paul A Fournier; Francesca Annan; Andrea E Scaramuzza; Dhruvi Hasnani; Sabine E Hofer
Journal:  Pediatr Diabetes       Date:  2018-10       Impact factor: 4.866

4.  Assessment of the 12-lead electrocardiogram as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 years of age): a scientific statement from the American Heart Association and the American College of Cardiology.

Authors:  Barry J Maron; Richard A Friedman; Paul Kligfield; Benjamin D Levine; Sami Viskin; Bernard R Chaitman; Peter M Okin; J Philip Saul; Lisa Salberg; George F Van Hare; Elsayed Z Soliman; Jersey Chen; G Paul Matherne; Steven F Bolling; Matthew J Mitten; Arthur Caplan; Gary J Balady; Paul D Thompson
Journal:  J Am Coll Cardiol       Date:  2014-09-15       Impact factor: 24.094

Review 5.  6. Glycemic Targets: Standards of Medical Care in Diabetes-2019.

Authors: 
Journal:  Diabetes Care       Date:  2019-01       Impact factor: 19.112

6.  Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia.

Authors:  Stacey M Anderson; Bruce A Buckingham; Marc D Breton; Jessica L Robic; Charlotte L Barnett; Christian A Wakeman; Mary C Oliveri; Sue A Brown; Trang T Ly; Paula K Clinton; Liana J Hsu; Ryan S Kingman; Lisa M Norlander; Sarah E Loebner; Suzette Reuschel-DiVirglio; Boris P Kovatchev
Journal:  Diabetes Technol Ther       Date:  2019-05-16       Impact factor: 6.118

7.  Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.

Authors:  Marcus Lind; William Polonsky; Irl B Hirsch; Tim Heise; Jan Bolinder; Sofia Dahlqvist; Erik Schwarz; Arndís Finna Ólafsdóttir; Anders Frid; Hans Wedel; Elsa Ahlén; Thomas Nyström; Jarl Hellman
Journal:  JAMA       Date:  2017-01-24       Impact factor: 56.272

8.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

9.  Efficacy of an Overnight Predictive Low-Glucose Suspend System in Relation to Hypoglycemia Risk Factors in Youth and Adults With Type 1 Diabetes.

Authors:  Peter M Calhoun; Bruce A Buckingham; David M Maahs; Irene Hramiak; Darrell M Wilson; Tandy Aye; Paula Clinton; Peter Chase; Laurel Messer; Craig Kollman; Roy W Beck; John Lum
Journal:  J Diabetes Sci Technol       Date:  2016-11-01

10.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

View more
  1 in total

1.  Comparison of venous, capillary and interstitial blood glucose data measured during hyperbaric oxygen treatment from patients with diabetes mellitus.

Authors:  Carol Baines; Don Vicendese; David Cooper; William McGuiness; Charne Miller
Journal:  Diving Hyperb Med       Date:  2021-09-30       Impact factor: 1.228

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.